Mode
Text Size
Log in / Sign up
N/A N=213 Randomized Single-blind Health Services Research

Engagement of Patients With Advanced Cancer

End of Life · Advanced Cancer · Lung Neoplasm · Gastric Cancer · Colon Cancer

Enrolled (actual)
213
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcome: Primary: Number of Participants With Completed Goals of Care Documentation. We Will Evaluate if 75% of Patients in the Intervention Arm Have a Documented Goals of Care Titled Medical Note Within 6 Months of Patient Enrollment in the Study. — 98; 26 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
EPAC (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Dec 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Completed Goals of Care Documentation. We Will Evaluate if 75% of Patients in the Intervention Arm Have a Documented Goals of Care Titled Medical Note Within 6 Months of Patient Enrollment in the Study.
98; 26
SECONDARY
Emergency Department Visit (Chart Review)
1.03; 1.20
SECONDARY
Emergency Department Visit (Chart Review)
1.03; 1.20
SECONDARY
Hospitalization Visits (Chart Review)
0.75; 0.88
SECONDARY
Hospitalization Visits (Chart Review)
0.75; 0.88
SECONDARY
Hospice Referral (Chart Review)
32; 16
SECONDARY
Palliative Care Referral (Chart Review)
31; 23
SECONDARY
Palliative Care Referral (Chart Review)
31; 23
SECONDARY
Change in Patient Satisfaction With Care Using the Consumer Assessment of Health Care Providers and Systems -General Survey
-0.54; -0.99
SECONDARY
Patient Satisfaction With Decision-Making Using the Satisfaction With Decision Survey
4.73; 4.15

Summary

The Engagement of Patients with Advanced Cancer is an intervention that utilizes well-trained lay health coaches to engage patients and their families in goals of care and shared decision-making after a diagnosis of advanced cancer. Although lay health workers have never been tested in this role, we hypothesize that lay health workers can feasibly improve goals of care documentation and help to reduce unwanted healthcare utilization at the end of life for Veterans diagnosed with new advanced stages of cancer and those diagnosed with recurrent disease.

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed stage III or IV cancer
  • Recurrent disease (any stage)
  • Ability to consent to study

Exclusion Criteria

  • Patients who are unable to consent to study procedures
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02966509). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search